|
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, applicable previous investigation(s), sample analysis, complaint and lot history review, applicable manufacture records, and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a leak in the needle housing was unconfirmed as the complaint could not be reproduced.The product returned for evaluation was (qty 2) 20 g x 1¿ w/y-site powerloc max infusion sets.Blood residue was seen within the tubing and needle housing, indicating use.None of these residue traces indicated a pathway for fluid to the exterior of the needle housing.Both samples were subsequently functionally tested for leakage by forceful infusion with a laboratory syringe and water combination, and neither device exhibited leakage through the system.A complaint history review found no potentially similar complaints for this product lot, and a review of the manufacture production records found no potentially related observations during production.The reported complaint issue will be included as part of ongoing trending and monitoring for potentially similar events.H3 other text : evaluation findings are in section h.11.
|